Alerts & Updates 8th Aug 2019

ELP Webinar : Emerging antitrust issues: Implications on India’s pharma industry : Summary

Authors

Ravisekhar NairPartner | Bengaluru

Latest Thought Leadership

Alerts & Updates 12th Mar 2026

USTR initiates Section 301 investigations over excess global capacity: Potential Implications for India

Read More
Alerts & Updates 11th Mar 2026

India’s new DPDP regime – What GDPR-compliant businesses should know

Read More
Alerts & Updates 10th Mar 2026

SEBI operationalizes the SWAGAT-FI framework for FPIs and FVCIs

Read More
Alerts & Updates 10th Mar 2026

SEBI Revamps and Replaces Its 30-Year-Old Regulations for Mutual Funds

Read More

ELP’s Competition Law & Policy team, in collaboration with Vinson & Elkins, hosted a webinar on July 18, 2019 on the topic of ‘Emerging antitrust issues: Implications on India’s pharma industry’. The attached note contains a summary of the salient points that were addressed during this event. Some interesting questions were raised during the interactive Q&A section. In case you are interested in hearing this discourse, please click here to access a recording of the panel discussion.

Read more

Privacy Policy

As per the rules of the Bar Council of India, lawyers and law firms are not permitted to solicit work or advertise. By clicking on the "I Agree" button, you acknowledge and confirm that you are seeking information relating to Economic Laws Practice (ELP) of your own accord and there has been no advertisement, personal communication, solicitation, invitation or any other inducement of any sort whatsoever by or on behalf of ELP or any of its members to solicit any work through this website.